Exploring the pathophysiological mechanisms and wet biomarkers of VPS13A disease
VPS13A disease (also known as Chorea-Acanthocytosis, ChAc) is a representative subtype of the neuroacanthocytosis (NA) syndromes, characterized by neurodegeneration in the central nervous system and acanthocytosis in peripheral blood. It is a rare autosomal recessive genetic disorder caused by loss-...
Saved in:
| Main Authors: | Jingqi Lin, Hongmei Meng, Nilupaer Shafeng, Jiaai Li, Huaiyu Sun, Xi Yang, Zhiqing Chen, Shuai Hou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1482936/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel loss-of-function mutations in VPS13A cause chorea-acanthocytosis in two families
by: Xiao-Hong Lin, et al.
Published: (2025-08-01) -
Editorial: Progress in neuroacanthocytosis syndromes and related diseases including other bulk lipid transfer disorders
by: Adrian Danek, et al.
Published: (2025-06-01) -
Impact of genetic test interpretation on a VPS13B missense variant in Cohen syndrome
by: Gudrun Schottmann, et al.
Published: (2024-12-01) -
Tiny-VPS: Tiny Video Panoptic Segmentation Standing on the Shoulder of Giant-VPS
by: Qingfeng Liu, et al.
Published: (2025-01-01) -
Multiple problems: a case of Cohen syndrome VPS13B mutation causing bilateral spherical lenses combined with retinitis pigmentosa
by: Yifan Wang, et al.
Published: (2025-08-01)